Ikena Oncology to Participate in Spring 2022 Investor Conferences
BOSTON, May 18, 2022 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA, “Ikena”), a targeted oncology company forging new territory in patient-directed cancer treatment, today announced that management will be presenting at the H.C. Wainwright Global Investment Conference, taking place May 23-26, 2022, and the Jefferies Global Healthcare Conference, taking place June 8-10, 2022.
Ikena CEO Mark Manfredi, Ph.D., will present a corporate update at the H.C. Wainwright Global Investment Conference and management will attend virtually. They will also participate in a fireside chat at the Jefferies Global Healthcare Conference and will attend the conference live in New York City.
Details can be found below:
About Ikena Oncology